-
1دورية أكاديمية
المؤلفون: Hughes, Gareth, Dark, Paul
المصدر: RECOVERY Collaborative Group , Hughes , G & Dark , P 2024 , ' Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY) : a randomised, controlled, open-label, platform trial ' , The Lancet. Child & adolescent health , vol. 8 , no. 3 , pp. 190-200 . https://doi.org/10.1016/S2352-4642Test(23)00316-4
مصطلحات موضوعية: Humans, Male, Child, Female, COVID-19/complications, SARS-CoV-2, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Immunoglobulins, Intravenous/therapeutic use, Bayes Theorem, Treatment Outcome, Methylprednisolone/therapeutic use, Inflammation, Immunomodulation, Systemic Inflammatory Response Syndrome
الإتاحة: https://doi.org/10.1016/S2352-4642Test(23)00316-4
https://research.manchester.ac.uk/en/publications/4c324435-1ff8-4b23-b729-558db148d055Test -
2دورية أكاديمية
المؤلفون: Ludwig, Heinz, Terpos, Evangelos, van de Donk, Niels, Mateos, Maria-Victoria, Moreau, Philippe, Dimopoulos, Melitios-Athanasios, Delforge, Michel, Rodriguez-Otero, Paula, San-Miguel, Jesús, Yong, Kwee, Gay, Francesca, Einsele, Hermann, Mina, Roberto, Caers, Jo, Driessen, Christoph, Musto, Pellegrino, Zweegman, Sonja, Engelhardt, Monika, Cook, Gordon, Weisel, Katja, Broijl, Annemiek, Beksac, Meral, Bila, Jelena, Schjesvold, Fredrik, Cavo, Michele, Hajek, Roman, Touzeau, Cyrille, Boccadoro, Mario, Sonneveld, Pieter
المصدر: The Lancet Oncology, 24 (6), e255 - e269 (2023-06)
مصطلحات موضوعية: cell-associated neurotoxicity, Antibodies, Bispecific, Interleukin 1 Receptor Antagonist Protein, Humans, Cytokine Release Syndrome/etiology, Cytokine Release Syndrome/prevention & control, Cytokine Release Syndrome/drug therapy, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Consensus, Immunotherapy, Adoptive/adverse effects, T-Lymphocytes, Multiple Myeloma/drug therapy, Antibodies, Bispecific/adverse effects, Cytokine Release Syndrome, Immunotherapy, Adoptive, Multiple Myeloma, Oncology, Human health sciences, Hematology, Sciences de la santé humaine, Hématologie
العلاقة: https://api.elsevier.com/content/article/PII:S1470204523001596?httpAccept=text/xmlTest; urn:issn:1470-2045; urn:issn:1474-5488
الوصول الحر: https://orbi.uliege.be/handle/2268/310482Test
-
3دورية أكاديمية
المؤلفون: Audemard-Verger, Alexandra, Le Gouge, Amélie, Pestre, Vincent, Courjon, Johan, Langlois, Vincent, Vareil, Marc-Olivier, Devaux, Mathilde, Bienvenu, Boris, Leroy, Vincent, Goulabchand, Radjiv, Colombain, Léa, Bigot, Adrien, Guimard, Thomas, Douadi, Youcef, Urbanski, Geoffrey, Faucher, Jean-François, Maulin, Laurence, Lioger, Bertrand, Talarmin, Jean-Philippe, Groh, Matthieu, Emmerich, Joseph, Deriaz, Sophie, Ferreira-Maldent, Nicole, Cook, Ann-Rose, Lengellé, Céline, Bourgoin, Hélène, Mékinian, Arsène, Aouba, Achille, Maillot, François, Caille, Agnès
المساهمون: Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Université de Tours (UT), Centre d’Investigation Clinique Tours CIC 1415 (CIC ), Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-Hôpital Bretonneau-Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Henri Duffaut (Avignon), Service d'infectiologie CHU Nice, Centre Hospitalier Universitaire de Nice (CHU Nice), Groupe Hospitalier du Havre Hôpital Jacques Monod (MONTIVILLIERS) (GHH), Centre Hospitalier de la Côte Basque (CHCB), Centre hospitalier intercommunal de Poissy/Saint-Germain-en-Laye - CHIPS Poissy, Hôpital Saint-Joseph Marseille, Clinique Teissier (Valenciennes) (AHNAC), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Service des Maladies Infectieuses et Tropicales, Centre Hospitalier de Perpignan, Centre Hospitalier Départemental - Hôpital de La Roche-sur-Yon (CHD Vendée), Centre hospitalier de Saint-Quentin, Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), Service des Maladies infectieuses et tropicales CHU Limoges, CHU Limoges, Epidémiologie des Maladies Chroniques en zone tropicale (EpiMaCT), CHU Limoges-Institut d'Epidémiologie Neurologique et de Neurologie Tropicale-Institut National de la Santé et de la Recherche Médicale (INSERM)-OmégaHealth (ΩHealth), Université de Limoges (UNILIM)-Université de Limoges (UNILIM), CH du Pays d'Aix, Aix-en-Provence, Centre Hospitalier de Blois (CHB), CH de Quimper, Hôpital Foch Suresnes, Groupe Hospitalier Paris Saint-Joseph (hpsj), Centre for Research in Epidemiology and Statistics, Conservatoire National des Arts et Métiers CNAM (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Département de Pharmacologie CHRU Tours, CHU Saint-Antoine AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)
المصدر: ISSN: 1932-6203.
مصطلحات موضوعية: MESH: Adult, MESH: COVID-19 Drug Treatment, MESH: Humans, MESH: Interleukin 1 Receptor Antagonist Protein / adverse effects, MESH: Interleukin 1 Receptor Antagonist Protein / therapeutic use, MESH: Respiration, Artificial, MESH: SARS-CoV-2, MESH: Treatment Outcome, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, [SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
العلاقة: hal-04064443; https://hal.science/hal-04064443Test; https://hal.science/hal-04064443/documentTest; https://hal.science/hal-04064443/file/journal.pone.0269065.pdfTest
الإتاحة: https://doi.org/10.1371/journal.pone.0269065Test
https://hal.science/hal-04064443Test
https://hal.science/hal-04064443/documentTest
https://hal.science/hal-04064443/file/journal.pone.0269065.pdfTest -
4دورية أكاديمية
المؤلفون: Durdzińska Timóteo, A., Dumusc, A., Durand, S.
المصدر: Hand surgery & rehabilitation, vol. 41, no. 6, pp. 701-706
مصطلحات موضوعية: Humans, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Wrist, Calcium, Retrospective Studies, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, Pain, Anakinra, Basic calcium phosphate, Blocage IL-1, Calcific periarthritis, Hand, IL-1 blockade, Main, Phosphate de calcium basique, Périarthrite calcifiante, Ultrasons, Ultrasound
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36087874; info:eu-repo/semantics/altIdentifier/eissn/2468-1210; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_437E3B239CC31; https://serval.unil.ch/notice/serval:BIB_437E3B239CC3Test; urn:issn:2468-1210; https://serval.unil.ch/resource/serval:BIB_437E3B239CC3.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_437E3B239CC31Test
الإتاحة: https://doi.org/10.1016/j.hansur.2022.08.009Test
https://serval.unil.ch/notice/serval:BIB_437E3B239CC3Test
https://serval.unil.ch/resource/serval:BIB_437E3B239CC3.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_437E3B239CC31Test -
5دورية أكاديمية
المؤلفون: Mikkelsen, Rasmus R, Hundahl, Malthe P, Torp, Christopher K, Rodríguez-Carrio, Javier, Kjolby, Mads, Bruun, Jens M, Kragstrup, Tue W
المصدر: Mikkelsen , R R , Hundahl , M P , Torp , C K , Rodríguez-Carrio , J , Kjolby , M , Bruun , J M & Kragstrup , T W 2022 , ' Immunomodulatory and immunosuppressive therapies in cardiovascular disease and type 2 diabetes mellitus : A bedside-to-bench approach ' , European Journal of Pharmacology , vol. 925 , 174998 . https://doi.org/10.1016/j.ejphar.2022.174998Test
مصطلحات موضوعية: Animals, Cardiovascular Diseases/drug therapy, Colchicine, Diabetes Mellitus, Type 2/complications, Etanercept/pharmacology, Humans, Hydroxychloroquine/therapeutic use, Immunosuppression Therapy, Inflammation/chemically induced, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Methotrexate/therapeutic use, Sulfasalazine/therapeutic use, Hydroxychloroquine/pharmacology, Immunomodulating Agents/pharmacology, Sulfasalazine/pharmacology, Colchicine/pharmacology, Interleukin-1/antagonists & inhibitors, Type 2/drug therapy, Interleukin 1 Receptor Antagonist Protein/pharmacology, Interleukin-1beta/antagonists & inhibitors, Antibodies, Monoclonal, Humanized/pharmacology, Immunosuppressive Agents/pharmacology, Inflammation/drug therapy, Methotrexate/pharmacology
وصف الملف: application/pdf
العلاقة: https://pure.au.dk/portal/da/publications/immunomodulatory-and-immunosuppressive-therapies-in-cardiovascular-disease-and-type-2-diabetes-mellitusTest(89dc7ad3-f029-46e6-b0e6-b29b06deb44c).html
الإتاحة: https://doi.org/10.1016/j.ejphar.2022.174998Test
https://pure.au.dk/portal/da/publications/immunomodulatory-and-immunosuppressive-therapies-in-cardiovascular-disease-and-type-2-diabetes-mellitusTest(89dc7ad3-f029-46e6-b0e6-b29b06deb44c).html
https://pure.au.dk/ws/files/352590179Test/1-s2.0-S001429992200259X-main.pdf -
6دورية أكاديمية
المساهمون: Jae Seok Kim, Jun Young Lee, Jae Won Yang, Keum Hwa Lee, Maria Effenberger, Wladimir Szpirt, Andreas Kronbichler, Jae Il Shin, Shin, Jae Il
مصطلحات موضوعية: Anti-Inflammatory Agents / pharmacology, Anti-Inflammatory Agents / therapeutic use, Antibodies, Monoclonal, Humanized / pharmacology, Humanized / therapeutic use, Azetidines / pharmacology, Azetidines / therapeutic use, COVID-19 / complications, COVID-19 / drug therapy, COVID-19 / immunology, COVID-19 / virology, Clinical Trials as Topic, Cytokine Release Syndrome / drug therapy, Cytokine Release Syndrome / immunology, Cytokines / antagonists & inhibitors, Cytokines / immunology, Cytokines / metabolism, Humans, Immunosuppressive Agents / pharmacology, Immunosuppressive Agents / therapeutic use, Interleukin 1 Receptor Antagonist Protein / pharmacology, Interleukin 1 Receptor Antagonist Protein / therapeutic use, Janus Kinases / antagonists & inhibitors, Janus Kinases / metabolism, Purines / pharmacology, Purines / therapeutic use, Pyrazoles / pharmacology, Pyrazoles / therapeutic use, SARS-CoV-2 / immunology
العلاقة: THERANOSTICS; J03103; OAK-2021-01759; https://ir.ymlib.yonsei.ac.kr/handle/22282913/181964Test; T202100024; THERANOSTICS, Vol.11(1) : 316-329, 2021-01
الإتاحة: https://doi.org/10.7150/thno.49713Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/181964Test -
7دورية أكاديمية
المؤلفون: Liu, Johnson M, Chi, Jeffrey
المصدر: Maine Medical Center
مصطلحات موضوعية: COVID-19, Cytokines, hemophagocytic lymphohistiocytosis, immunobiology, immunology/microbiology/virology, inflammation, Antibodies, Monoclonal (therapeutic use), Neutralizing (therapeutic use), COVID-19 (complications), Cytokine Release Syndrome (etiology, therapy, virology), Humans, Interleukin 1 Receptor Antagonist Protein (therapeutic use), Lymphohistiocytosis, Hemophagocytic (diagnosis, etiology, immunology, therapy)
العلاقة: https://knowledgeconnection.mainehealth.org/mmc/2223Test; https://pubmed.ncbi.nlm.nih.gov/35068219Test/
-
8
المؤلفون: Caroline Vinit, Sophie Georgin-Lavialle, Aikaterini Theodoropoulou, Catherine Barbier, Alexandre Belot, Manel Mejbri, Pascal Pillet, Jana Pachlopnik, Sylvaine Poignant, Charlotte Rebelle, Andreas Woerner, Isabelle Koné-Paut, Véronique Hentgen
المساهمون: Centre Hospitalier de Versailles André Mignot (CHV), Service de Médecine Interne [CHU Tenon], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Lausanne University Hospital, Centre Hospitalier Universitaire [Grenoble] (CHU), Service de néphrologie, rhumatologie et dermatologie pédiatriques [Hôpital Femme Mère Enfant, HCL], Hospices Civils de Lyon (HCL)-Hôpital Mère Enfant, CHU Bordeaux [Bordeaux], Département de pédiatrie [CHU Nantes], Centre hospitalier universitaire de Nantes (CHU Nantes), CHU de Bordeaux Pellegrin [Bordeaux], University Children’s Hospital Basel = Hôpital pédiatrique universitaire des deux Bâle [Bâle, Suisse] (UKBB), Service de Rhumatologie [CHU Bicêtre], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Bicêtre
المصدر: Frontiers in Immunology, Vol 12 (2021)
Frontiers in immunology, vol. 12, pp. 744780
Frontiers in Immunology
Frontiers in Immunology, Frontiers, 2021, 12, ⟨10.3389/fimmu.2021.744780⟩مصطلحات موضوعية: Male, Familial Mediterranean fever, interleukin-1 blockers, Adolescent, Adult, Aged, Antibodies, Monoclonal, Humanized/therapeutic use, Antirheumatic Agents/therapeutic use, Child, Child, Preschool, Female, Hereditary Autoinflammatory Diseases/complications, Hereditary Autoinflammatory Diseases/drug therapy, Humans, Infant, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Interleukin-1/antagonists & inhibitors, Middle Aged, Retrospective Studies, Young Adult, anakinra, autoinflammatory diseases, canakinumab, hereditary recurrent fevers, indications, treatment, 0302 clinical medicine, Quality of life, Immunology and Allergy, Original Research, 0303 health sciences, Mevalonate kinase deficiency, Interleukin, 3. Good health, Antirheumatic Agents, [SDV.IMM]Life Sciences [q-bio]/Immunology, medicine.drug, medicine.medical_specialty, Immunology, MEDLINE, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, Internal medicine, medicine, 030304 developmental biology, 030203 arthritis & rheumatology, Anakinra, business.industry, Hereditary Autoinflammatory Diseases, RC581-607, medicine.disease, Canakinumab, Interleukin 1 Receptor Antagonist Protein, Immunologic diseases. Allergy, Complication, business, Interleukin-1
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e625e3774c42c4cbcb268ba3e8a594dTest
https://www.frontiersin.org/articles/10.3389/fimmu.2021.744780/fullTest -
9دورية أكاديمية
المؤلفون: Saag, K.G., Khanna, P.P., Keenan, R.T., Ohlman, S., Osterling Koskinen, L., Sparve, E., Åkerblad, A.C., Wikén, M., So, A., Pillinger, M.H., Terkeltaub, R.
المصدر: Arthritis & rheumatology, vol. 73, no. 8, pp. 1533-1542
مصطلحات موضوعية: Adult, Aged, 80 and over, Arthralgia/drug therapy, Arthralgia/etiology, Double-Blind Method, Female, Gout/complications, Gout/drug therapy, Humans, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Male, Middle Aged, Pain Measurement, Patient Reported Outcome Measures, Symptom Flare Up, Treatment Outcome, Triamcinolone/therapeutic use
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33605029; info:eu-repo/semantics/altIdentifier/eissn/2326-5205; https://serval.unil.ch/notice/serval:BIB_152DC8683A89Test; urn:issn:2326-5191
الإتاحة: https://doi.org/10.1002/art.41699Test
https://serval.unil.ch/notice/serval:BIB_152DC8683A89Test -
10
المؤلفون: Kearsley-Fleet, Lianne, Beresford, Michael W, Davies, Rebecca, De Cock, Diederik, Baildam, Eileen, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy, Hyrich, Kimme L, Dis, Biologics Children Rheumatic
المساهمون: Public Health Sciences
المصدر: Rheumatology (Oxford, England)
RHEUMATOLOGY
Kearsley-Fleet, L, Beresford, M W, Davies, R, De Cock, D, Baildam, E, Foster, H E, Southwood, T R, Thomson, W, Hyrich, K L & Biologics for Children with Rheumatic Diseases Study (BCRD) 2019, ' Short-Term Outcomes in Patients with Systemic Juvenile Idiopathic Arthritis Treated with either Tocilizumab or Anakinra ', Rheumatology (Oxford), vol. 58, no. 1, pp. 94-102 . https://doi.org/10.1093/rheumatology/key262Testمصطلحات موضوعية: Male, Time Factors, Epidemiology, Arthritis, Antirheumatic Agents/therapeutic use, Outcome measures, Severity of Illness Index, Biologic Therapies, chemistry.chemical_compound, 0302 clinical medicine, Pharmacology (medical), Arthritis, Juvenile/drug therapy, 030212 general & internal medicine, Child, skin and connective tissue diseases, Statistics, Induction Chemotherapy, Clinical Science, Treatment Outcome, Antibodies, Monoclonal, Humanized/therapeutic use, statistics, Antirheumatic Agents, Child, Preschool, Cohort, epidemiology, Female, Biological Products/therapeutic use, medicine.drug, musculoskeletal diseases, medicine.medical_specialty, Antibodies, Monoclonal, Humanized, Interleukin 1 Receptor Antagonist Protein/therapeutic use, outcome measures, 03 medical and health sciences, Tocilizumab, Rheumatology, biologic therapies, Internal medicine, Severity of illness, medicine, Humans, Juvenile Idiopathic Arthritis, JIA, 030203 arthritis & rheumatology, Biological Products, Anakinra, business.industry, Induction chemotherapy, medicine.disease, Arthritis, Juvenile, Interleukin 1 Receptor Antagonist Protein, Logistic Models, chemistry, Macrophage activation syndrome, business
وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff89dce7fd1afb5b2ae4989dbed4d264Test
https://doi.org/10.1093/rheumatology/key262Test